Spots Global Cancer Trial Database for Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
Official Title: Prospective Study Assessing Predictive Value of 18 F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose (FDG) Positron Emission Tomography During Radio-chemotherapy for Locally Advanced Epidermoid Carcinoma of Head and Neck
Study ID: NCT02469922
Study Description
Brief Summary: Open multicentric study assessing predictive value of 18-FDG PET (SUV max) at 20 Gy during radio-chemotherapy, on the loco-regional control after 2 years
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Brest, Brest, , France
Centre jean Bernard - Rue Victor Hugo, Le Mans, , France
Hôpital du Scorff, Lorient, , France
Centre Eugene Marquis, Rennes, , France
Centre d'Oncologie St Vincent - Boulevard de la Boutière, Saint Grégoire, , France
Contact Details
Name: Castelli Joël, Doctor
Affiliation: Centre de Lutte Contre le Cancer Centre Eugène Marquis
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
